CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 甲磺酸帕珠沙星Pazufloxacin Mesylate
Pazufloxacin Mesylate

甲磺酸帕珠沙星 杂质对照品Pazufloxacin Mesylate Impurities

16 个杂质条目16 impurity entries

本页汇总 甲磺酸帕珠沙星 的 16 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 16 impurity reference standards of Pazufloxacin Mesylate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

甲磺酸帕珠沙星 —— 原料药与杂质对照品Pazufloxacin Mesylate — drug substance & impurities

共 16 个条目(含原料药本体)16 items incl. the drug substance
Pazufloxacin Mesylate structure
原料药 APIAPI
甲磺酸帕珠沙星Pazufloxacin Mesylate
Pazufloxacin Mesylate
CAS No.163680-77-1
Chemical FormulaC17H19FN2O7S
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin structure
—
帕珠沙星Pazufloxacin
Pazufloxacin
CAS No.127045-41-4
Chemical FormulaC16H15FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate-d4 structure
—
甲磺酸帕珠沙星-d4Pazufloxacin Mesylate-d4
Pazufloxacin Mesylate-d4
CAS No.1346602-97-8
Chemical FormulaC16H11D4FN2O4·CH4O3S
Purity>95%询价On request
Pazufloxacin Mesylate Impurity 6 structure
6
甲磺酸帕珠沙星杂质6Pazufloxacin Mesylate Impurity 6
Pazufloxacin Mesylate Impurity 6
CAS No.164851-44-9
Chemical FormulaC16H14FNO6
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 7 structure
7
甲磺酸帕珠沙星杂质7Pazufloxacin Mesylate Impurity 7
Pazufloxacin Mesylate Impurity 7
CAS No.171567-48-9
Chemical FormulaC15H15FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 8 structure
8
甲磺酸帕珠沙星杂质8Pazufloxacin Mesylate Impurity 8
Pazufloxacin Mesylate Impurity 8
CAS No.479348-49-7
Chemical FormulaC20H19FN2O6
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 12 structure
12
甲磺酸帕珠沙星杂质12Pazufloxacin Mesylate Impurity 12
Pazufloxacin Mesylate Impurity 12
CAS No.677004-96-5
Chemical FormulaC16H15FN2O4·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 13 structure
13
甲磺酸帕珠沙星杂质13Pazufloxacin Mesylate Impurity 13
Pazufloxacin Mesylate Impurity 13
CAS No.777824-29-0
Chemical FormulaC15H15FN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 14 structure
14
甲磺酸帕珠沙星杂质14Pazufloxacin Mesylate Impurity 14
Pazufloxacin Mesylate Impurity 14
CAS No.127046-18-8
Chemical FormulaC18H19FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 15 structure
15
甲磺酸帕珠沙星杂质15Pazufloxacin Mesylate Impurity 15
Pazufloxacin Mesylate Impurity 15
CAS No.165071-09-0
Chemical FormulaC14H9FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 16 structure
16
甲磺酸帕珠沙星杂质16Pazufloxacin Mesylate Impurity 16
Pazufloxacin Mesylate Impurity 16
CAS No.165071-03-4
Chemical FormulaC16H14FNO5
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 17 structure
17
甲磺酸帕珠沙星杂质17Pazufloxacin Mesylate Impurity 17
Pazufloxacin Mesylate Impurity 17
CAS No.165071-10-3
Chemical FormulaC14H10FNO6
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 21 (rac-Pazufloxacin Mesylate) structure
21
甲磺酸帕珠沙星杂质21 (消旋甲磺酸帕珠沙星)Pazufloxacin Mesylate Impurity 21 (rac-Pazufloxacin Mesylate)
Pazufloxacin Mesylate Impurity 21 (rac-Pazufloxacin Mesylate)
CAS No.136905-87-8
Chemical FormulaC16H15FN2O4·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 22 structure
22
甲磺酸帕珠沙星杂质22Pazufloxacin Mesylate Impurity 22
Pazufloxacin Mesylate Impurity 22
CAS No.1296306-33-6
Chemical FormulaC17H15FN2O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 23 structure
23
甲磺酸帕珠沙星杂质23Pazufloxacin Mesylate Impurity 23
Pazufloxacin Mesylate Impurity 23
CAS No.112738-68-8
Chemical FormulaC4H6F3N
Purity>95%询价On request
10mg25mg50mg100mg
Pazufloxacin Mesylate Impurity 12-d4 structure
12-D4
甲磺酸帕珠沙星杂质12-d4Pazufloxacin Mesylate Impurity 12-d4
Pazufloxacin Mesylate Impurity 12-d4
CAS No.1346602-24-1
Chemical FormulaC16H11D4FN2O4·CH4O3S
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

甲磺酸帕珠沙星 杂质谱研究要点Pazufloxacin Mesylate — impurity profiling notes

下面这些是拿到 甲磺酸帕珠沙星 的 16 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 16 impurity entries for Pazufloxacin Mesylate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances